Sight is developing a variety of diagnostic tools, including a rapid complete blood count (CBC) finger-prick test that’s launching in Europe this week and is in clinical trials in the U.S.
Read more on Forbes here.
Sight is developing a variety of diagnostic tools, including a rapid complete blood count (CBC) finger-prick test that’s launching in Europe this week and is in clinical trials in the U.S.
Read more on Forbes here.